SAGE PRO

Home / Research / CIE Automotive India Limited

SAGE PRO · ORIGINAL EQUITY RESEARCH

CIE Automotive India Limited — Q2 FY27 Results Analysis

Quarterly consolidated sales and EBITDA

Published · Quarter Q2 FY27 · CIEINDIA

PeriodQ3 CY2026 / September 2026 quarter
COMPANY-SPECIFIC GRAPHICAL SUMMARY

What the reported figures reveal

CHART 1

Quarterly consolidated sales and EBITDA

Sales Q3 CY25₹23,097 million
Sales Q3 CY26₹25,585 million
EBITDA Q3 CY25₹3,748 million
EBITDA Q3 CY26₹4,178 million

https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d3ef204-d4ac-4789-b056-5067b6810571.pdf

CHART 2

Domestic demand expands

Q3 CY25₹15,232 million
Q2 CY26₹16,549 million
Q3 CY26₹18,010 million

https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d3ef204-d4ac-4789-b056-5067b6810571.pdf

CHART 3

Sales growth outpaced operating profit

Q3 CY2517.3 % EBITDA
Q2 CY2616.7 % EBITDA
Q3 CY2616.3 % EBITDA

https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d3ef204-d4ac-4789-b056-5067b6810571.pdf

CHART 4

European market pressure and seasonality

Q3 CY25₹7,866 million
Q2 CY26₹8,883 million
Q3 CY26₹7,575 million

https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d3ef204-d4ac-4789-b056-5067b6810571.pdf

ORIGINAL RESEARCH INSIGHTS

Investment findings and watch points

RESEARCH INSIGHT

Quarterly consolidated sales and EBITDA

India drives sales; Europe offsets India margin pressure

Watch: Monitor geographic margin and revenue separately

RESEARCH INSIGHT

Domestic demand expands

Domestic demand expands

Watch: Monitor geographic margin and revenue separately

RESEARCH INSIGHT

Sales growth outpaced operating profit

Sales growth outpaced operating profit

Watch: Monitor geographic margin and revenue separately

RESEARCH INSIGHT

European market pressure and seasonality

European market pressure and seasonality

Watch: Monitor geographic margin and revenue separately

FULL PUBLISHED RESEARCH

Earnings and management commentary analysis

CIE Automotive India Limited | July–September 2026 | Q3 CY2026 / Q2 FY2027 comparison window | WATCH

Investor decision. The quarter ended 30 September 2026 is Q3 CY2026 in this calendar-year reporting company, although it occupies the September quarter used by Sage PRO's Q2 FY27 comparison calendar. This distinction is essential: the cumulative figures below are nine months ended September 2026, not H1 FY27. CIE India's growth engine is domestic automotive components, while European restructuring protects group profitability against a sluggish end market. Consolidated quarterly sales were ₹25,585 million versus ₹23,097 million a year earlier; EBITDA was ₹4,178 million versus ₹3,748 million; consolidated EBITDA margin was 16.3% versus 16.2%. The modest margin improvement conceals a 100-basis-point decline in India's margin and a 220-basis-point increase in Europe's margin. [S1]

Investment thesis: watch for the domestic growth-and-capex cycle to translate into incremental operating profit without permanently depressing margins. The company has not supplied a valuation multiple, share price or forward earnings model in these two filings, so no numerical fair value or price target is asserted. A higher valuation would require evidence of profitable new-order ramp-up, recovery of India cost pass-through and durable European profitability, not merely strong automotive industry production statistics. [S1][S2]

Key takeaways

  • Consolidated Q3 CY26 sales ₹25,585 million, up approximately 10.8% against Q3 CY25 ₹23,097 million. [S1]
  • Consolidated Q3 EBITDA ₹4,178 million, up approximately 11.5% against ₹3,748 million; the company's presentation rounds growth to 11%. [S1]
  • India Q3 sales ₹18,010 million, up 18%; India EBITDA margin 16.3% versus 17.3%. [S1]
  • Europe Q3 sales ₹7,575 million, down approximately 3.7%; Europe EBITDA margin 16.3% versus 14.1%. [S1]
  • Nine-month consolidated PAT ₹7,287 million, up approximately 16.8% versus ₹6,239 million. [S1]
  • Management indicated India's CY26 growth capex would be approximately double the prior year's and discussed an indicative capex intensity around 8% of sales, versus a more typical 5%. These are management indications, not audited cash expenditure or guaranteed budgets. [S2]

Chapter 1 — Investor decision and valuation discipline

The central decision is whether to pay for two different engines: strong India revenue growth with near-term cost pressure, and European margin repair in an essentially flat end market. The combined group delivered Q3 EBIT of ₹3,249 million versus ₹2,858 million and EBT of ₹3,216 million versus ₹2,824 million. Those are operating outcomes, not evidence of a cheap share price. [S1]

For a bullish investment case, require improving India margin alongside delivery of capacity additions and preservation of European restructuring gains. For a neutral case, allow India sales growth but only gradual price recovery, with Europe largely stable. A bearish case follows if higher growth capex arrives before orders convert to profitable revenue, and customer pricing fails to offset raw material, energy and consumables inflation. These are conditional analytical frameworks, not company forecasts.

The current WATCH stance is deliberately conditional: there is no independently sourced market price, enterprise value, net-debt reconciliation or earnings estimate in this two-document source set. A price-to-earnings or EV/EBITDA assertion would be unsupported. The appropriate valuation test is whether subsequent filings show a better return on the announced capital programme, supported by cash generation and a sustained EBITDA margin. [S1][S2]

Decision tests

  • Check whether India margin recovers from 16.3% without sacrificing the 18% quarterly sales growth base. [S1]
  • Compare European EBITDA margin with 16.3%, rather than assuming restructuring can repeat indefinitely. [S1]
  • Demand evidence that growth capex is creating sales and cash, not only installed capacity. [S2]

Chapter 2 — Reported financial performance and earnings quality

All figures in ₹ million, unless marked otherwise. The presentation defines EBITDA as net operating income plus depreciation and EBIT as net operating income. These management-defined operating measures must not be silently equated with statutory profit or compared with differently adjusted peer EBITDA. [S1]

MetricQ3 CY26Q3 CY25Q2 CY26Interpretation
Consolidated sales25,58523,09725,432Strong year-on-year growth; little sequential movement
Consolidated EBITDA4,1783,7484,183Year-on-year increase, sequentially flat
Consolidated EBITDA margin16.3%16.2%16.4%Group stability masks geography divergence
Consolidated EBIT3,2492,8583,212Improvement from both regions
Consolidated EBT3,2162,8243,120Below EBIT because of net below-EBIT items
India sales18,01015,23216,54918% year-on-year
India EBITDA2,9402,6422,76911% growth, below sales growth
Europe sales7,5757,8668,883Weak year-on-year; seasonal Q3 sequential decline
Europe EBITDA1,2381,1061,414Profit rises despite weaker sales

For nine months ended September 2026, consolidated sales reached ₹76,427 million against ₹67,965 million; EBITDA ₹12,664 million against ₹11,053 million; EBIT ₹9,820 million against ₹8,427 million; EBT ₹9,614 million against ₹8,263 million; PAT ₹7,287 million against ₹6,239 million. Consolidated EBITDA margin was 16.6% versus 16.3%, and PAT margin 9.5% versus 9.2%. These cumulative nine-month figures should never be presented as six-month/H1 totals. [S1]

India's nine-month sales were ₹50,748 million versus ₹43,935 million, but its EBITDA margin fell to 16.9% from 17.8%. India PAT was ₹5,071 million versus ₹4,700 million. Europe's nine-month sales were ₹25,679 million versus ₹24,030 million; EBITDA increased to ₹4,101 million from ₹3,231 million and PAT to ₹2,216 million from ₹1,538 million. The regional combination explains why consolidated profit growth outpaced India's PAT growth. [S1]

Earnings-quality watchpoints

  • Operating EBITDA growth should be reconciled to statutory PAT, taxes and working-capital cash flow before extrapolation.
  • India's sales growth exceeds its EBITDA growth, showing negative operating leverage from costs despite healthy demand.
  • Europe's profit recovery reflects prior restructuring; avoid treating it as indefinitely repeatable.
  • The presentation contains statutory-format statements, but these excerpts do not establish a complete consolidated operating cash-flow bridge. [S1]

Chapter 3 — Segment economics and end-market exposure

CIE India manufactures components across forgings, aluminium, stampings, gears, composites and iron castings. It does not publish individual vertical EBITDA margins in the earnings call; management explicitly declined an analyst's request for those margins. Therefore no vertical profitability ranking is invented. The most defensible segment split in the supplied materials is India versus Europe, with disclosed regional sales, EBITDA and market conditions. [S2]

India represented approximately 70.4% of Q3 consolidated sales (₹18,010 million divided by ₹25,585 million), while Europe represented approximately 29.6%. These percentages are derived from reported figures, not an issuer-published segment-mix percentage. India sales growth was driven by robust vehicle demand, although management noted that tractor growth had moderated. Europe faced a stagnant auto market and rising Chinese import competition. [S1][S2]

The issuer presentation's external market-production series are industry indicators, not CIE's own shipment volumes: India light vehicles grew 18.8% year-on-year in Q3 CY26, two-wheelers 16.7%, tractors 6.8% and medium/heavy commercial vehicles 11.7% on the presentation's IHS series, with an explicit warning about divergence among truck-data providers. European light-vehicle production was up 0.3%, and medium/heavy commercial vehicles down 0.8%. The business may gain or lose content per vehicle independently of these industry changes. [S1]

Operating questions

  • Is the 18% India sales increase primarily underlying market growth, customer wins, content gains or price/mix?
  • Are price-recovery negotiations sufficiently fast to protect India margin?
  • Will Europe's restructuring gains withstand subdued production and imports?
  • How will aluminium diversification alter customer concentration and product mix? [S1][S2]

Chapter 4 — Execution, new programmes and management Q&A

Management outlined several identifiable capacity and product initiatives. Aluminium plans to diversify into four-wheeler high-pressure die-casting components, requiring new lines. Stampings plans expansion at multiple locations linked to expectations from its two principal customers. Gears and composites have electric-vehicle orders; iron castings is close to full foundry capacity; forgings plans expansion in Pune and Hosur. These are management descriptions of projects and demand opportunities, not evidence that all projects have commenced commercial production. [S2]

The analyst Q&A surfaced three consequential issues. First, the difference between India-segment and standalone revenue includes CIE Hosur and aluminium; management said the aluminium merger was awaiting an NCLT order. The presentation also notes that CIE Aluminium Casting India Limited's merger remains subject to approvals. Second, management does not disclose each vertical's margin. Third, it identified energy, gases and consumables as causes of rising other expenses and said customer pass-through was being pursued. [S1][S2]

Management was asked about relocating European assets to the parent and about repurchases. The CEO did not commit to a Europe restructuring transaction and said the Indian company was not considering a buyback at that point because cash was earmarked for organic expansion. He also indicated that attractive acquisition opportunities were not evident at reasonable valuations. Neither remark should be turned into a definitive capital-allocation policy for future years. [S2]

Milestone ledger

  • Track commissioning and utilisation of the planned aluminium four-wheeler HPDC lines.
  • Track stampings capacity at the sites associated with two major customers.
  • Track EV programme revenue conversion in gears and composites.
  • Track foundry debottlenecking and Pune/Hosur forging capacity, rather than treating announced projects as booked revenue. [S2]

Chapter 5 — Cash, capex, debt and payback discipline

The clearest capital-allocation disclosure is qualitative and directional. Management expects India's CY26 growth capex to be approximately twice the prior year's level and indicated a similar overall growth-capex level might persist in CY27. The CEO contrasted a typical capex intensity around 5% of sales with a possible period near 8%. These are forward-looking management comments; they do not prove actual cash outflow, signed order coverage or an investment return. [S2]

The company described a net-cash position and a preference to fund organic expansion instead of an Indian share repurchase. However, the reviewed presentation/call excerpts do not provide a reliable date-matched consolidated gross debt, lease obligations, cash balance or free-cash-flow bridge. Accordingly, this report does not fabricate a net-cash amount, debt ratio, ROIC or project payback period. A future update should obtain the statutory cash-flow statement and capex schedule before quantifying any of them. [S2]

The risk is timing: fixed assets may be paid for before new customer programmes generate sales. Higher capex could be sensible if it lifts future volumes and content, but it could also depress near-term free cash flow. The decision rule is to monitor commissioned capacity, operating cash conversion, receivables/inventory growth, and incremental EBITDA per rupee of deployed capital.

Capital monitoring

  • Separate actual investing cash flow from management's indicated growth-capex intentions.
  • Check whether capital spending coincides with volume ramp-up and gross-margin recovery.
  • Watch cash conversion when India sales expand faster than EBITDA.
  • Do not infer a buyback or acquisition from the absence of one today. [S1][S2]

Chapter 6 — Conditional bull, base and bear outcomes

Bull case — profitable India scale. New orders in stampings, aluminium, EV-related gears/composites and forgings move into commercial output; India pricing catches up with energy and consumable inflation; Europe's restructured plants retain operating leverage. The observable falsifier is persistent India EBITDA margin at or below the Q3 CY26 16.3% level despite stronger capacity utilisation, or a reversal of Europe's 16.3% quarterly margin. This is a scenario, not a company earnings forecast. [S1][S2]

Base case — growth with mixed margins. India continues to benefit from auto production but growth moderates as management expects the effect of GST changes to diminish. Europe remains flat in sales with reasonably stable profitability. Growth capex precedes some of its associated earnings. The evidence test is sequential India sales and margin development, plus European sales against the same seasonal quarter in the prior year, not simply quarter-on-quarter Europe revenue. [S1][S2]

Bear case — capex ahead of profitability. Raw-material and energy costs resist pass-through; European competition worsens; large customer programmes are delayed or yield inadequate returns. If the announced India capex increase coincides with weak operating cash flow, the risk is not just lower reported EBITDA margin but poor cash payback. The falsifier for this negative case would be verifiable commissioning, margin recovery and cash conversion. [S2]

No scenario here includes an invented target price, share count, probability-weighted valuation, expected stock return or issuer-approved profit forecast. The required missing inputs are a consistent valuation date, price, debt/cash and capital employed, plus evidence-backed assumptions.

Chapter 7 — Practical investment action plan and quarterly scorecard

Current action: WATCH, with evidence-based escalation only. The strongest favourable fact is domestic sales growth; the most important counterweight is weaker India margin. Europe supplies an offsetting margin improvement but has weaker underlying demand. The capex decision makes future cash conversion and capacity utilisation especially important. [S1][S2]

MonitorQ3 CY26 / 9M CY26 baselineNext-quarter decision test
India revenueQ3 ₹18,010m, +18% YoYCompare like-for-like demand, customer ramp and price/mix
India EBITDA marginQ3 16.3%; 9M 16.9%Check pass-through and input-cost relief
Europe revenueQ3 ₹7,575m, down ~4% YoYUse seasonal year-on-year comparison
Europe EBITDA marginQ3 16.3%; 9M 16.0%Test durability of restructuring gains
Consolidated EBITDAQ3 ₹4,178m; 9M ₹12,664mTest incremental profit against new sales
Consolidated PAT9M ₹7,287mReconcile statutory profit with cash
India growth capexCY26 ~2x prior year, management indicationCompare actual spending with commissioning
Project deliveryMultiple expansions announcedVerify operational start, capacity and returns

Potential catalysts include concrete progress on the aluminium merger, commissioning of new HPDC and forging lines, EV programme shipments, improving Indian cost pass-through, and sustained European profitability. Risks include raw-material inflation, customer concentration in stamping programmes, slower automotive demand, weak European imports/competition dynamics and capex without sufficient cash return. [S1][S2]

Research limitations specific to this decision: no verified current valuation, no complete cash/debt reconciliation, no vertical margin disclosure and no individual project payback schedule in these two accepted filings. The industry market-production data in the issuer presentation should not be treated as CIE's own volume growth. Future updates should explicitly identify the reported period as Q4 CY26 when the December 2026 quarter becomes available, rather than incorrectly describing this calendar-year company as a March-ending fiscal issuer.

Original issuer/exchange filings

  • [S1] [BSE-filed CIE Automotive India Q3 and 9M CY2026 investor presentation, 22 October 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d3ef204-d4ac-4789-b056-5067b6810571.pdf)
  • [S2] [BSE-filed CIE Automotive India Q3 CY2026 earnings-call transcript, call 22 October, filed 26 October 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/02561454-5a9b-4bc4-8a3f-707e9b827d39.pdf)

Figures use the filing's management-defined operating EBITDA basis where stated; arithmetic described as derived is calculated from the presentation's reported values.

Additional company evidence

CHART 5

Higher margin on weaker sales

Q3 CY2514.1 % EBITDA
Q2 CY2615.9 % EBITDA
Q3 CY2616.3 % EBITDA

https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d3ef204-d4ac-4789-b056-5067b6810571.pdf

CHART 6

January–September sales expansion

9M CY25₹67,965 million
9M CY26₹76,427 million

https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d3ef204-d4ac-4789-b056-5067b6810571.pdf

CHART 7

Profit growth exceeds sales growth

9M CY25₹11,053 million
9M CY26₹12,664 million

https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d3ef204-d4ac-4789-b056-5067b6810571.pdf

CHART 8

Bottom-line growth

9M CY25₹6,239 million
9M CY26₹7,287 million

https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d3ef204-d4ac-4789-b056-5067b6810571.pdf

SOURCE REFERENCES

Original disclosures and investor presentations

  1. Issuer disclosure
  2. Issuer disclosure

Related research and comparisons

Other published Q2 FY27 reports

This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.